The Prodromes and Early Detection of Alzheimer's Disease

Early Detection and Management of Mental Disorders

Volumn , Issue , 2005, Pages 277-294

  Zaudig, Michael ^a  

^a Windach Hospital and Institute for Neurobehavioral Research and Therapy   (Germany)

Author keywords

Activities of daily living (ADL); Age associated cognitive decline (AACD); Alzheimer's disease (AD); Asymptomatic AD; Biomarkers in cerebrospinal fluid (CSF); Dementia; Mild cognitive impairment (MCI); NINCDS ADRDA criteria; Subjective cognitive impairment

Indexed keywords

EID: 33644793304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470010851.ch10     Document Type: Chapter

References (66)

1. Zaudig M. (2002). Mild cognitive impairment in the elderly. Curr. Opin. Psychiatry, 15(1), 387-393.
2. Burns A., Zaudig M. (2002). Mild cognitive impairment in older people. Lancet, 360, 1963-1965.
3. Feinstein A.R. (1972). Clinical biostatistics: 13. On homogeneity, taxonomy, and nosography. Clin. Pharmacol. Ther., 13, 114-129.
4. Zaudig M., Mittelhammer J., Hiller W., Pauls A., Thora C., Morinigo A., Mombour W. (1991). SIDAM-a structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other etiology according to ICD-10 and DSM-III-R. Psychol. Med., 21, 225-236.
5. Roth M., Thym E., Mountjoy C.Q., Huppert F.A, Hendrie H., Verma S., Goddard R. (1986). CAMDEX. A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry, 149, 698-709.
6. Ritchie K., Artero S., Touchon J. (2001). Classification criteria for mild cognitive impairment. A population-based validation study. Neurology, 56, 37-42.
7. Lopez O.L., Jagust W.J., DeKosky S.T., Becker J.T., Fitzpatrick A., Breitner J., Lyketsos C., Jones B., Kawas C., Carlson M., et al. (2003). Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Part 1. Arch. Neurol., 60, 1385-1389.
8. Visser P.J. (2000). Predictors of Alzheimer Type Dementia in Subjects with Mild Cognitive Impairments. Maastricht University Press, Maastricht, pp. 134-139.
9. Devanand D., Sano M., Tang M., Taylor S., Gurland B., Wilder D., Stern Y., Mayeux R. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch. Gen. Psychiatry, 53, 175-182.
10. Jorm A., van Duijn C., Chandra V., Fratiglioni L., Graves A., Heyman A. (1991). Psychiatric history and related disorders as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol., 20, 43-47.
11. Yaffe K., Blackwell T., Gore R., Sands L., Reus V., Browner W. (1999). Depressive symptoms and cognitive decline in nondemented elderly women. Arch. Gen. Psychiatry, 56, 425-430.
12. Alexopoulous G.S., Meyers B.S., Young J.C., Mattis S., Kakuma T. (1993). The course of geriatric depression with ''reversible dementia'': a controlled study. Am. J. Psychiatry, 150, 1693-1699.
13. Kral V., Emery O. (1989). Long-term follow-up of depressive pseudodementia. Can. J. Psychiatry, 34, 445-466.
14. Hill C.D., Stoudemire A., Morris R., Martino-Salzman D., Markwalter H.R. (1992). Similarities and differences in memory deficits in patients with primary dementia and depression-related cognitive dysfunction. J. Neuropsychiatr. Clin. Neurosci., 5, 277-282.
15. Kukull W.A., Larson E.P., Reifler B.V., Lampe T.H., Jerby M.S., Hughes J.P. (1990). The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology, 40, 1364-1369.
16. Waite L.M., Broe G.A., Grayson D.A., Creasey H. (2001). Preclinical syndromes predict dementia: the Sydney older persons study. J. Neurol. Neurosurg. Psychiatry, 71, 296-302.
17. Erkinjuntti T., Ostbye T., Steenhuis R., Palo J. (1997). The effect of different diagnostic criteria on the prevalence of dementia. N. Engl. J. Med., 337, 1667- 1674.
18. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. (2001). Mild cognitive impairment represents early-stage Alzheimer's disease. Arch. Neurol., 58, 397-405.
19. Flicker C., Ferris S.H., Reisberg B. (1991). Mild cognitive impairment in the elderly: predictors of dementia. Neurology, 41, 1006-1009.
20. Tierney M.C., Szalai J.P., Snow W.G., Fisher R.H., Nores A., Nadon G., Dann E., St. George-Hylop P.H. (1996). Prediction of probable Alzheimer's disease in memory-impaired patient: a prospective longitudinal study. Neurology, 46, 661-665.
21. Bowen J., Teri L., Kukull W., McCormick W., McCurry S.M., Larson E.B. (1997). Progression to dementia in patients with isolated memory loss. Lancet, 349, 763-765.
22. Devanand D.P., Folz M., Gorlyn M., Moeller J.R., Stern Y. (1997). Questionable dementia: clinical course and predictors of outcome. J. Am. Geriatr. Soc., 45, 321-328.
23. Wolf H., Grunwald M., Ecke G.M., Bettin S., Zedlick D., Dannenberg C., Dietrich J., Eschrich K., Arendt T., Gertz H.J. (1998). The prognosis of mild cognitive impairment in the elderly. J. Neural Transm., 54, 31-50.
24. Krasucki J.S., Alexander G.E., Horwitz B., Daly E.M., Murphy D.G., Rapoport S.J., Schapiro M.B. (1998). Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry, 43, 60-68.
25. Petersen R.C., Smith G.E., Waring S.C., Irnik R.J., Tangalos E.G., Kokmen E. (1999). Mild cognitive impairment. Clinical characterization and outcome. Arch. Neurol., 56, 303-308.
26. Black S.E. (1999). Can SPECT predict the future for mild cognitive impairment? Can. J. Neurol. Sci., 26, 4-6.
27. McKelvey R., Bergman H., Stern J. (1999). Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Can. J. Neurol. Sci., 26, 23-28.
28. Daly E., Zaitchik D., Copeland M., Schmahmann J., Gunther J., Albert M. (2000). Predicting conversion to Alzheimer disease using standardized clinical information. Arch. Neurol., 57, 675-680.
29. Bozoki A., Giordani B., Heidebrink J.L., Berent S., Foster N.L. (2001). Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch. Neurol., 58, 401-416.
30. Tabert M.H., Albert S.M. (2002). Functional deficits in patients with mild cognitive impairment. Prediction of AD. Neurology, 58, 758-764.
31. Palmer K., Wang H., Bäckman L., Winblad B., Fratiglioni L. (2002). Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am. J. Psychiatry, 159, 436-442.
32. Folstein M.F., Folstein S.E., McHugh P.R. (1975). Mini-Mental-State: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12, 189-198.
33. Zaudig M., Hiller W. (1996). SIDAM-Handbuch. Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der vaskulären Demenz und Demenzen anderer Ätiologien nach DSM-III-R, DSM-IV und ICD-10. Hans Huber, Bern.
34. Mohs R.C., Rosen W.G., Davis K.L. (1983). The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol. Bull., 19, 448-450.
35. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. (1982). A new clinical scale for the staging of dementia. Br. J. Psychiatry, 140, 566-572.
36. Henderson A.S. (1992). The Canberra Interview for the Elderly: a new field instrument for the diagnoses of dementia and depression by ICD-10 and DSMIII- R. Acta Psychiatr. Scand., 85, 105-113.
37. Reisberg B., Ferris S.H., Leon M.J., Crook T. (1982). The Global Deterioration Scale (GDS): an instrument for the assessment of primary degenerative dementia (PDD). Am. J. Psychiatry, 139, 1135-1139.
38. Ritchie K., Touchon J. (2000). Mild cognitive impairment: conceptual basis and current nosological status. Lancet, 355, 225-228.
39. Welsh K.A., Butters N., Hughes J.P., Mohs R.C., Heyman A. (1992). Detection on staging of dementia in Alzheimer's disease. Use of the Neuropsychological Measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch. Neurol., 49, 448-452.
40. Petersen R.C., Doody R., Kurz A., Mohs R., Morris J.C., Rabins P.V., Ritchie K., Russor M., Thal L., Winblad B. (2001). Current concepts in mild cognitive impairment. Neurology, 58, 1985-1992.
41. Jorm A.F., Jacomb P.A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol. Med., 19, 1015-1022.
42. Reisberg B., Finkel S., Overall J., Schmidt-Gollas N., Kanowski S., Hulla F., Selan S., Wilms H.-U., Lehfeld H., Heininger K., et al. (2001). The Alzheimer's Disease Activities of Daily Living International Scale (ADL-IS). Int. Psychogeriatr., 13, 163-181.
43. Touchon J., Ritchie K. (1999). Prodromal cognitive disorder in Alzheimer's disease. Int. J. Geriatr. Psychiatry, 14, 556-563.
44. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKell D.W., Morris J.C. (2001). Neuron number in the entorhinal cortex and CA I in preclinical Alzheimer disease. Arch. Neurol., 58, 1395-1402.
45. Goldman W.P., Price J.L., Storandt M., Grant E.A., McKeel D.W., Rubin E.H., Morris J.C. (2001). Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology, 56, 361-367.
46. Price J.L., Morris J.C. (1999). Tangles and plaques in non-demented aging and preclinical Alzheimer's disease. Ann. Neurol., 45, 358-368.
47. Collie A., Maruff P., Shafiq-Antonacci R., Smith M., Hallup M., Schofield R.P., Maslers C.C., Currie J. (2001). Memory decline in healthy older people. Implication for identifying mild cognitive impairment. Neurology, 56, 1533-1538.
48. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziota J.C., Small G.W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med., 343, 450-456.
49. Schmand B., Jonker C., Geerlings M.I., Lindeboom J. (1997). Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br. J. Psychiatry, 171, 373-376.
50. Geerlings M.E., Jonker C., Bouter L.M., Ader J.J., Schmand B. (1999). Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am. J. Psychiatry, 156, 531-537.
51. Jorm A.F., Chistensen H., Korten A.E., Henderson A.S., Jacomb P.A., Mackinnon A. (1997). Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol. Med., 27, 91-98.
52. Jorm A.F., Christensen H., Korten A.E., Jacomb P.A., Henderson A.S. (2001). Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years. Psychol. Med., 31, 441-449.
53. Hogan D.B., Ebly E.M. (2000). Predicting who will develop dementia in a cohort of Canadian seniors. Can. J. Neurol. Sci., 27, 18-24.
54. Schofield P.W., Marder K., Dooneief G., Jacobs D.M., Sano M., Stern Y. (1997). Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am. J. Psychiatry, 154, 609-615.
55. Dik M.G., Jonker C., Comijs H.C., Bouter L.M., Twisk J.W.R., van Kamp G.J., Deeg D.J.H. (2001). Memory complaints and APOE-e4 accelerate cognitive decline in cognitively normal elderly. Neurology, 57, 217-222.
56. DeGroot J.C., deLeuw F.E., Oudkerk M., Hofman A., Jolles J., Breteler M.M.B. (2001). Cerebral white matter lesions and subjective cognitive dysfunction. The Rotterdam Scan Study. Neurology, 56, 1539-1545.
57. Hampel H., Buerger K., Zinkowski R., Teipel S.J., Goernitz A., Andreasen N., Sjoegren M., DeBernardis J., KerkmanD., Ichiguro K., et al. (2004).Measurement of phosphorylatedtau epitopes in the differential diagnoses of Alzheimer's disease.A comparative cerebrospinal fluid study. Arch. Gen. Psychiatry, 61, 95-102.
58. Sunderland T., Wolozin B., Galasko D. (1999). Longitudinal stability of CSF tau levels in Alzheimer patients. Biol. Psychiatry, 46, 750-755.
59. Galasko D. (1999). Cerebrospinal fluid opens a window on Alzheimer's disease. Arch. Neurol., 56, 655-656.
60. Okamura N., Arai H., Maroyama M., Iguchi M., Mazui T., Tanji H., Seki T., Hirai H., Chiba H., Itoh M., et al. (2002). Combined analysis of CSF tau levels and [(123)I] iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am. J. Psychiatry, 159, 474-476.
61. Kantarci K., Xu Y., Shiung M.M. (2002). Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. J. Dem. Geriatr. Cogn. Dis., 14, 198-207.
62. DeSanti S., DeLion M.J., Rusinek H., Convit A., Tarshik C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisly K., et al. (2001). Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging, 22, 529-539.
63. Kennedy A.M., Frackowiak R.S., Newman S.K. (1995). Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett., 186, 17-20.
64. Kordower J.H., Chu Y., Stebbins G.T., Dekosky S.T., Cochran E.J., Bennet D., Mufson E.J. (2001). Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Neurology, 49, 202-213.
65. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., Yaffe K., Kramer J.H., Reed B., Norman D., et al. (2001). Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, 71, 441-447.
66. Robins E., Guze S. (1970). Establishment of diagnostic validity in psychiatric illnesses: its application to schizophrenia. Am. J. Psychiatry, 126, 983-987.